Prenetics Global (PRENW) EBITDA Margin (2021 - 2026)

Prenetics Global has disclosed EBITDA Margin across 6 years of filings, most recently posting 1.02% for Q1 2026.

• In Q1 2026, EBITDA Margin fell 182.0% year-over-year to 1.02%; the TTM figure through Mar 2026 stood at 11.35% (up 12031.0% YoY), while the FY2025 annual figure was 0.53%, up 505.0% from the prior year.
• EBITDA Margin grew to 1.02% in Q1 2026, from 3.18% in the prior quarter.
• Over the last five years, EBITDA Margin for PRENW reached as high as 2025.75% in Q2 2024 and fell as low as 3547.81% in Q2 2022.
• The 5-year median for EBITDA Margin is 36.41% (2022), against an average of 201.04%.
• Annual changes were most pronounced in 2022 — EBITDA Margin slumped 353525 bps — and 2023, when it soared 323430 bps.
• A 5-year view of EBITDA Margin shows it stood at 153.54% in 2022, then slumped by 323 bps to 342.54% in 2023, then soared by 98 bps to 6.45% in 2024, then soared by 51 bps to 3.18% in 2025, then surged by 68 bps to 1.02% in 2026.
• According to Business Quant data, EBITDA Margin over the past three periods registered 1.02%, 3.18%, and 5.46% for Q1 2026, Q4 2025, and Q3 2025 respectively.